Monitoring of Self-Paced Action Timing and Sensory Outcomes After Lesions to the Orbitofrontal Cortex.


Journal

Journal of cognitive neuroscience
ISSN: 1530-8898
Titre abrégé: J Cogn Neurosci
Pays: United States
ID NLM: 8910747

Informations de publication

Date de publication:
01 08 2021
Historique:
entrez: 10 8 2021
pubmed: 11 8 2021
medline: 5 11 2021
Statut: ppublish

Résumé

Anticipation, monitoring, and evaluation of the outcome of one's actions are at the core of proactive control. Individuals with lesions to OFC often demonstrate behaviors that indicate a lack of recognition or concern for the negative effects of their actions. Altered action timing has also been reported in these patients. We investigated the role of OFC in predicting and monitoring the sensory outcomes of self-paced actions. We studied patients with focal OFC lesions (n = 15) and healthy controls (n = 20) while they produced actions that infrequently evoked unexpected outcomes. Participants performed a self-paced, random generation task where they repeatedly pressed right and left buttons that were associated with specific sensory outcomes: a 1- and 2-kHz tone, respectively. Occasional unexpected action outcomes occurred (mismatch) that inverted the learned button-tone association (match). We analyzed ERPs to the expected and unexpected outcomes as well as action timing. Neither group showed post-mismatch slowing of button presses, but OFC patients had a higher number of fast button presses, indicating that they were inferior to controls at producing regularly timed actions. Mismatch trials elicited enhanced N2b-P3a responses across groups as indicated by the significant main effect of task condition. Planned within-group analyses showed, however, that patients did not have a significant condition effect, suggesting that the result of the omnibus analysis was driven primarily by the controls. Altogether, our findings indicate that monitoring of action timing and the sensory outcomes of self-paced actions as indexed by ERPs is impacted by OFC damage.

Identifiants

pubmed: 34375421
pii: 101850
doi: 10.1162/jocn_a_01733
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1956-1975

Subventions

Organisme : NINDS NIH HHS
ID : NS21135
Pays : United States

Informations de copyright

© 2021 Massachusetts Institute of Technology.

Auteurs

Anne-Kristin Solbakk (AK)

University of Oslo, Norway.
Oslo University Hospital-Rikshospitalet, Norway.
Helgeland Hospital, Mosjøen, Norway.

James Lubell (J)

University of Oslo, Norway.
Aarhus University, Aarhus, Denmark.

Sabine Leske (S)

University of Oslo, Norway.

Ingrid Funderud (I)

University of Oslo, Norway.
Helgeland Hospital, Mosjøen, Norway.

Anaïs Llorens (A)

Oslo University Hospital-Rikshospitalet, Norway.
University of California at Berkeley.

Alejandro O Blenkmann (AO)

University of Oslo, Norway.

Maja Dyhre Foldal (MD)

University of Oslo, Norway.

Torstein R Meling (TR)

Geneva University Hospitals, Switzerland.

Robert T Knight (RT)

University of California at Berkeley.

Tor Endestad (T)

University of Oslo, Norway.
Helgeland Hospital, Mosjøen, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH